Dalfampridine: FDA adverse event reports
77,124 FDA FAERS reports mention Dalfampridine. 24,753 reports have a serious outcome flag.
Reported reactions
- Gait Disturbance: 11,376 reports
- Drug Ineffective: 8,538 reports
- Fall: 7,825 reports
- Fatigue: 5,826 reports
- Multiple Sclerosis Relapse: 5,128 reports
- Balance Disorder: 5,094 reports
- Therapy Cessation: 4,619 reports
- Dizziness: 4,260 reports
- Urinary Tract Infection: 4,054 reports
- Asthenia: 3,711 reports
- Condition Aggravated: 3,568 reports
- Headache: 3,474 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.